Now Free Shipping When Buying $100 Plus of Herbs

NuLignan tablets 90's, Health Concerns


Item #:

90090

Price:

Login to See Pricing

NuLignan

sold only to licensed practitioners & students of tcm!

 

NuLignan

7-hydroxymatairesinol extract

 

Therapeutic Actions

 

1. Promotes hormonal health by promoting the body's own production of

enterolactone, which has been found to be protect against developing

tumors and cardiovascular disease

 

2. Enterolactone reduces circulating estrogen, and blocks aromatase, binds to

estrogen receptors and blocks estrogen activity in specific selected tissues,

inhibits cancer cell growth and signaling. When estrogen levels decline,

enterolactone levels may mimic the effects of estrogen, when estrogen

levels are high, enterolactone occupies and blocks estrogen receptors

 

3. Reduces hot flashes; may support bone health

 

4. Antioxidant, anti-inflammatory

 

Administration

 

Internal:

For hot flashes and for acute conditions use 2 tablets day.

Maintenance dosage 1 tablet per day

90 tablets, 25mg, 30 day supply

 

Ingredient

A patented extract of

7-hydroxymatairesinol extracted from

Norway Spruce Trees (Picea abies)

 

Formula Rationale

Lignans are phyto-nutrients found in unrefined grain products, seeds, fruits and

vegetables. Friendly intestinal bacteria converts plant lignans into human lignans such

as enterolactone. When there are low estrogen levels in the body these weak lignan

estrogens make up for some of the insufficiency. When estrogen from endogenous or

exogenous sources is abundant, enterolactone reduces the activity of estrogen by

occupying estrogen binding sites. As a result, plant lignans are thought to influence the

development of breast, prostate, and colon cancers that depend on hormones to start

and progress. Lignans also support cardiovascular health and help to moderate other

estrogen dependant conditions such as menopausal symptoms and osteoporosis.

Case control studies in Finland found an inverse association between serum

enterolactone and the risk of breast cancer both among pre-menopausal and postmenopausal

women. These findings have been duplicated in case control studies in

Australia and the UK. In a study conducted by the Roswell Park Cancer Institute, U.S.A,

of 1,122 women with primary breast cancer, and 2,036 control subjects, that those with

the highest dietary intake of lignans had a reduced breast cancer risk.

Research has shown that enterolactone acts weakly on the physiological estrogen

balance and offers a natural method for managing menopausal symptoms. In an eight

week study, the equivalent to two tablets of NuLignan™ was found to increase

enterolactone levels and significantly reduce hot flashes at week four, with further

reductions at week eight. Additional studies suggest that lignans improve menopausal

symptoms, and maintain cognitive function in postmenopausal women. Recent studies

suggest a link between lignan consumption and bone reabsorption, and improved lipid

profiles. Lignans are also thought to contribute to prostate health by inhibiting cancer

cell growth and signaling.

 

NuLignan is a new generation, highly bioavailable lignan formula. It is the first direct

enterolactone precursor supplement, standardized to 90 percent pure lignans as 7-

hydroxymatairesinol. In addition, it is a strong antioxidant, and may help to modulate

inflammatory reactions. Pharmacokinetic studies show that NuLignan is rapidly

absorbed, elevates enterolactone concentration, and has an excellent safety profile.

 

 

No Health claims or other representations Herbal products are food supplements. All statements made describing all products that are sold and or distributed by Acu-Market have not been evaluated by the Food and Drug Administration. All herbal and homeopathic products sold by Acu-Market are not meant to treat, cure or prevent disease. Under no circumstances does Acu-Market imply that all (any) products and formulas are meant to diagnose, treat, cure or prevent any disease.

Loading...